{
    "medicine_id": "77fd9c2f7c445149161f1314e5f19939657cdcf6",
    "platform_id": "DB09332",
    "metadata": {
        "name": "Darzalex 20 mg ml Injection solution concentrate",
        "composition": "20 mg ml Kappadione",
        "clinical_particulars": {
            "therapeutic_indications": "Anticoagulant induced prothrombin deficiency caused by coumadin or indanedione derivatives prophylaxis and therapy of hemorrhagic disease of the newborn hypoprothrombinemia due to antibacterial therapy hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin K for example obstructive jaundice biliary fistula sprue ulcerative colitis celiac disease intestinal resection cystic fibrosis of the pancreas and regional enteritis other drug induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin K metabolism L1545 L1546",
            "contraindications": {
                "disease": "This medication has been associated with increased risk of kernicterus and hemolytic anemia in premature infants L1562 It is not advisable to administer this medication in newborns and those with G6PD due to free radical cycling by this medication This increases risk of free radical damage to the liver and hemolytic anemia L1570",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Menadiol sodium diphosphate is a highly water soluble vitamin K analog The presence of vitamin K is necessary for the formation of prothrombin factor VII factor IX and factor X Lack of vitamin K results in an increased risk of hemorrhage which can be minor or life threatening L1566",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}